Welcome to MicThera, a pioneering biotech startup at the forefront of revolutionizing prostate cancer treatment. Committed to advancing healthcare through cutting-edge science, we specialize in the discovery and development of microbial derived therapeutics. Our groundbreaking approach harnesses the intricate dynamics of the microbiota to identify promising therapeutic candidates derived from commensal bacteria.
With exclusive licensing rights to patented technologies, we are driving forward the discovery of a new class of medicines. Our team of experts is dedicated to meticulously researching, with the ultimate goal of offering novel, effective treatments for prostate cancer patients.
Join us on our mission to reshape the landscape of cancer therapeutics through pioneering research, strategic partnerships, and a steadfast commitment to improving patient outcomes.
Company Details
- Employees
- 5
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.micthera.com
- Keywords
- Bellinzona.
Micthera Questions
Micthera's website is http://www.micthera.com
Micthera's LinkedIn profile is https://www.linkedin.com/company/micthera
Micthera has
5 employees.
View email and phone details for 5
employees at Micthera.
Micthera's industry is
Biotechnology Research
Micthera's top competitors are
Indaco Venture Partners,
Hornet Therapeutics,
Hoba Therapeutics,
Usi Startup Centre,
Healiva®,
Haya Therapeutics,
Invirtuolabs,
Fuse Diagnostics,
Institute Of Oncology Research (Ior),
Anthropos.
Micthera's categories are Biotechnology Research
Micthera's founding year is 2023
